EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The evaluation of an automated chemiluminescent immunoassay for complexed PSA on the Bayer ADVIA CentaurTM system



The evaluation of an automated chemiluminescent immunoassay for complexed PSA on the Bayer ADVIA CentaurTM system



Clinical Chemistry 47(S6): A127, June




(PDF emailed within 1 workday: $29.90)

Accession: 035885000

Download citation: RISBibTeXText



Related references

Evaluation of allergen specific human IgE assays for the Bayer ADVIA CentaurTM automated chemiluminescent immunoassay system. Clinical Chemistry & Laboratory Medicine 39(Special Supplement): S127, 2001

Development of allergen specific human IgE on the Bayer ADVIA CentaurTM automated chemiluminescent immunoassay system. Clinical Chemistry 47(S6): A44, June, 2001

Evaluation of an automated chemiluminescent immunoassay for complexed PSA on the Bayer ACS:180 system. Journal of Clinical Laboratory Analysis 17(5): 174-178, 2003

An automated chemiluminescent immunoassay for complexed PSA on the Bayer ACS180 system evaluated. Clinical Chemistry & Laboratory Medicine 39(Special Supplement): S164, 2001

An evaluation of an automated homocysteine method on the Bayer ADVIA Centaur automated chemiluminescent system. Clinical Laboratory 48(9-10): 493-496, 2002

Development of an automated chemiluminescent immunoassay for TPO autoantibodies on the Bayer ACS180 and ADVIA Centaur systems. Clinical Chemistry 47(S6): A112, June, 2001

Development of an automated chemiluminescent immunoassay for anti-TPO autoantibodies on the Bayer ACS180 and ADVIA Centaur systems. Clinical Chemistry & Laboratory Medicine 39(Special Supplement): S135, 2001

Development of a fully automated sandwich immunoassay for the quantitative measurement of serum CA 15-3TM on ADVIA CentaurTM system. Clinical Chemistry 47(S6): A137, June, 2001

Development of an automated test for B-type Natriuretic Peptide as an aid in the diagnosis and evaluation of congestive heart failure on the Bayer ADVIA Centaur chemiluminescent system. Clinical Chemistry 48(6 Supplement): A85, June, 2002

Multi-site evaluation of a chemiluminescent Rubella IgM assay for the ADVIA CentaurTM. Abstracts of the General Meeting of the American Society for Microbiology 101: 185, 2001

Evaluation of the Bayer ADVIA Centaur immunoassay system and ACS180 immunoassay system valproic acid assays. Clinical Chemistry 48(6 Supplement): A48-A49, June, 2002

Evaluation of the Bayer ADVIA Centaur immunoassay system CA 125 assay. Clinical Chemistry 49(S6): A102, June, 2003

An anti-HIV-1 rO/HIV-2 assay on the Bayer ADVIA CentaurTM. Clinical Chemistry 47(S6): A96, June, 2001

Clinical performance of the Bayer ADVIA CentaurTM CA 15-3 assay. Clinical Chemistry 48(6 Supplement): A16, June, 2002

Development of the Bayer ADVIA CentaurTM CA125 II assay. Clinical Chemistry 47(S6): A134, June, 2001